Purpose Male breast cancer (BC) is rare, representing approximately 1% of cancers that
occur in men and approximately 1% of all BCs worldwide. Because male BC is rare, not …

Male breast cancer (MBC) is a rare disease, accounting for less than 1% of all breast cancer
diagnoses worldwide. Although breast carcinomas share certain characteristics in both …

Male breast cancer (MaleBC) is a rare disease, accounting for< 1% of all male tumors.
During the last few years, there has been an increase in the incidence of this disease, along …

To determine the impact of adjuvant treatment with tamoxifen and aromatase inhibitors (AI)
on the survival of men with breast cancer. We analyzed 257 male patients with hormone …

Male breast cancer (MaBC) is a rare clinical entity, which makes up approximately 1% of all
breast cancers. However, the incidence of MaBC has been steadily increasing over the past …

Male breast carcinoma is a rare condition. Few male breast cancer-specific epidemiological
or clinical trial data are available-our understanding of male breast cancer thus comes from …

Background Breast cancer is rare in men and managed by extrapolating from breast cancer
in women. The clinicopathological features of male breast cancer, however, differ from those …

Male breast cancer (MBC) is extremely rare, with an incidence in the general US population
of< 1%. It tends to be diagnosed at later stages than breast cancer in females, likely because …

Breast cancer is the most prevalent type of cancer in women and responsible for significant
female cancer-related mortality worldwide. In the Western world, over 80% of breast cancers …

Introduction Male breast cancer (MBC) is a rare and inadequately characterized disease.
The aim of the present study was to characterize MBC tumors transcriptionally, to classify …